Our consortium partner PhosPrint was selected as one of the finalists of the 13th annual SPIE Startup Challenge! The final pitch presentations will take place at SPIE Photonics West in San Francisco on 31 January 2023.
After 1.5 years of project implementation, the Tumor-LN-oC consortium recently gathered in Athens for the M18 project meeting. The 2-day consortium meeting was followed by the first periodic review meeting.
Tumor-LN-oC partner AMIRES kindly invites you to the 2nd Regenerative Medicine workshop which will take place on Wednesday, October 12th 2022, in Prague. Registrations are open now!
From 12-14 May 2022, the Tumor-LN-oC consortium met at TU/e in Eindhoven for the project's M12 progress meeting. The Meeting officially concluded the first year of the project.
The European Health and Digital Executive Agency (HaDEA) has featured Tumor-LN-oC in a special article on its website for World... View Article
As one of the components of the Tumor-LN-oC platform, consortium partner PhosPrint is working on a laser bioprinting process for OrganOnChip (OoC) and sensor applications. PhosPrint representative Simos Papazoglou presented the project progress at SPIE Photonics Europe last week.
Tumor-LN-oC team member Symeon Papazoglou from PhosPrint is presenting his article “Laser bioprinting of cell-laden bioinks for organ-on-chip and sensor... View Article
With the conclusion of Month 10 of the project, Tumor-LN-oC consortium successfully passed the second milestone of the project: the final selection of specifications for materials, processes and user requirements.
To better understand the end-user requirements for the tumor-lymph node-on-chip platform, that will be developed during the course of the project, we have prepared a short questionnaire which you are invited to contribute to!
On the 18th and 19th of November, the Tumor-LN-oC consortium met for the M6 meeting in Athens. The meeting closed... View Article
